CompletedPhase 2NCT01830465

VELCADE® Plus Rituximab in Non Hodgkin's Follicular Lymphoma

Studying Follicular lymphoma

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Gruppo Italiano Studio Linfomi
Principal Investigator
Stefano Sacchi, MD
Gruppo Italiano Studio Linfomi
Intervention
Bortezomib (VELCADE)(drug)
Enrollment
45 enrolled
Eligibility
18-90 years · All sexes
Timeline
2006 – 2011

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01830465 on ClinicalTrials.gov

Other trials for Follicular lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Follicular lymphoma →

← Back to all trials